Compagnie Lombard Odier SCmA - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 55 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Compagnie Lombard Odier SCmA ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$1,0000.0%2,2000.0%0.00%
Q3 2016$1,000
-50.0%
2,2000.0%0.00%
Q2 2016$2,0000.0%2,2000.0%0.00%
Q1 2016$2,000
-33.3%
2,2000.0%0.00%
Q4 2015$3,0002,2000.00%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q4 2015
NameSharesValueWeighting ↓
Virtu KCG Holdings LLC 86,824$31,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$17,0000.00%
DEUTSCHE BANK AG\ 1,405$00.00%
CITIGROUP INC 9,751$4,0000.00%
GOLDMAN SACHS GROUP INC 17,281$6,0000.00%
MORGAN STANLEY 4,250$2,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 48,944$18,0000.00%
BlackRock Inc. 927,688$334,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 6,600$2,0000.00%
Bank of New York Mellon Corp 62,846$22,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders